Transaction · 0000892251-26-000125

Troendle August J.

Troendle August J., PRES, CEO, reported an open-market or private sale at Medpace Holdings, Inc. involving 27174.000000 shares for an estimated $16814999.46. Reported holdings after the transaction were 561195.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES, CEO
MEDPMedpace Holdings, Inc.
Filing timeAug 21
Trade dateAug 20, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$620.75
Pre-filing
1mo ago -14.4%1w ago -6.3%1d ago -2.0%
Returns since
7d -3.2%30d -3.2%90d -3.2%180d -3.2%1y -3.2%

MEDP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MEDP since 2026-08-21Filed 13 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000892251-26-000125
Common Stock
Transaction date
Aug 20, 2026
Filed Aug 21, 2026, 08:13 PM · 1d delay
Shares
27.1k sh
$61.8k per share
Estimated value
-$1.68B
Computed from shares × price
Holdings after
561k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & CEO

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

  2. F2

    The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $601.29 to $611.42. The Reporting Person undertakes to provide full pricing information to…

  3. F3

    The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $606.20 to $626.51. The Reporting Person undertakes to provide full pricing information to…

  4. F4

    The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Report…

Original filing · 0000892251-26-000125
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MEDP